Lunai Bioworks (LNAI) Profit After Tax (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Profit After Tax of -$2.6 million in Q1 2026, down 42.9% quarter-over-quarter from -$1.8 million in Q4 2025, and down 1459.26% on a YoY basis from $189176.0 in Q1 2025.
Lunai Bioworks (LNAI) Profit After Tax (2011 - 2026) Analysis & Trends
Lunai Bioworks' Profit After Tax history runs 16 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 1459.26% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$128.3 million (down 91.45% YoY), while the FY2025 annual figure was -$178.0 million, down 101.31% from the prior year.
- Profit After Tax was -$2.6 million for Q1 2026 at Lunai Bioworks, down from -$1.8 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $2.8 million in Q3 2025 to a low of -$126.7 million in Q2 2025.
- Historically, Profit After Tax has averaged -$23.8 million across 5 years, with a median of -$7.3 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax surged 106.38% in 2025, then slumped 1459.26% in 2026.
- A 5-year view of Profit After Tax shows it stood at -$4.5 million in 2022, then dropped by 1.6% to -$4.5 million in 2023, then plunged by 60.13% to -$7.3 million in 2024, then soared by 75.19% to -$1.8 million in 2025, then plunged by 42.9% to -$2.6 million in 2026.
- The last three Profit After Tax figures came in at -$2.6 million (Q1 2026), -$1.8 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | -2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | -1.80 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | -126.73 Mn |
| Mar 31, 2025 | 189,176.00 |
| Dec 31, 2024 | -7.25 Mn |
| Sep 30, 2024 | -44.21 Mn |
| Jun 30, 2024 | -15.73 Mn |
| Mar 31, 2024 | -58.99 Mn |
| Dec 31, 2023 | -4.53 Mn |
| Sep 30, 2023 | -9.18 Mn |
| Jun 30, 2023 | -23.20 Mn |
| Mar 31, 2023 | -4.33 Mn |
| Dec 31, 2022 | -4.46 Mn |
| Sep 30, 2022 | -7.70 Mn |
| Jun 30, 2022 | -90.24 Mn |
| Mar 31, 2022 | -6.20 Mn |
| Dec 31, 2021 | -6.58 Mn |
| Sep 30, 2021 | -10.41 Mn |
| Jun 30, 2021 | -17.36 Mn |